Mutants of the LAG-3 proteins and nucleotides encoding LAG-3 mutants
US6482925B1 · kind B1 · utility
43Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 6, 2000 |
| Grant date | Nov 19, 2002 |
| Priority date | — |
| Expiry date | Jan 6, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns a purified polypeptide corresponding to a mutated form of the soluble LAG-3 protein or of one of its fragments comprising the extra-cellular domain D1 and D2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.